Amyris News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

10.08.23	Amyris Commences Voluntary Chapter 11 Proceedings In U.S. Bankruptcy Court (RTTNews)
10.08.23	AMYRIS ANNOUNCES OPERATIONAL AND FINANCIAL RESTRUCTURING TO ADVANCE STRATEGIC TRANSFORMATION (PR Newswire)
26.06.23	Amyris CEO John Melo Resigns; Han Kieftenbeld To Be Interim Chief Executive (RTTNews)
26.06.23	AMYRIS ANNOUNCES CEO TRANSITION AND GLOBAL REDUCTION IN FORCE (PR Newswire)
05.06.23	AMYRIS INITIATES STRATEGIC TRANSFORMATION PROGRAM AND SECURES FUNDING (PR Newswire)
19.05.23	AMYRIS COMPLETES LICENSE FOR SUPPLY OF SUSTAINABLE SQUALENE (PR Newswire)
09.05.23	AMYRIS, INC. REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS (PR Newswire)
02.05.23	AMYRIS TO HOST FIRST QUARTER 2023 FINANCIAL RESULTS CONFERENCE CALL ON MAY 9 (PR Newswire)
24.04.23	AMYRIS REPORTS Q1 2023 REVENUE (PR Newswire)
05.04.23	AMYRIS CLOSES STRATEGIC TRANSACTION WITH GIVAUDAN (PR Newswire)
15.03.23	AMYRIS, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS (PR Newswire)
28.02.23	AMYRIS TO HOST FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS CONFERENCE CALL ON MARCH 15, 2023 (PR Newswire)
22.02.23	GIVAUDAN TO ACQUIRE PORTFOLIO OF MAJOR COSMETIC INGREDIENTS FROM AMYRIS AND TO ESTABLISH STRATEGIC PARTNERSHIP FOR NATURAL, SUSTAINABLY SOURCED INGREDIENTS FOR THE BEAUTY INDUSTRY (PR Newswire)
30.01.23	AMYRIS LAUNCHES 4U BY TIA™ HAIRCARE LINE EXCLUSIVELY AT WALMART (PR Newswire)
04.01.23	AMYRIS TO PRESENT AT THE 41st ANNUAL J.P. MORGAN HEALTH CARE CONFERENCE (PR Newswire)
29.12.22	AMYRIS ANNOUNCES $50 MILLION REGISTERED DIRECT OFFERING AND CONCURRENT PRIVATE PLACEMENT (PR Newswire)
27.12.22	AMYRIS SUCCESSFULLY ADVANCES STRATEGIC TRANSACTION (PR Newswire)
30.11.22	AMYRIS CONSUMER BRANDS DELIVER 80% CYBER MONDAY LIKE-FOR-LIKE GROWTH (PR Newswire)
28.11.22	AMYRIS CONSUMER BRANDS DELIVER RECORD BLACK FRIDAY WEEK SALES (PR Newswire)
08.11.22	AMYRIS, INC. REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS (PR Newswire)
01.11.22	AMYRIS TO HOST THIRD QUARTER 2022 FINANCIAL RESULTS CONFERENCE CALL ON NOVEMBER 8 (PR Newswire)
25.10.22	Amyris and World Wildlife Fund Announce Partnership to Protect Biodiversity (PR Newswire)
24.10.22	AMYRIS SUCCESSFULLY LAUNCHES TWO NEW CONSUMER BRANDS (PR Newswire)
11.10.22	Amyris Brands Expanding in UK and Europe. Executing on continued accelerated growth and lower costs (PR Newswire)
07.09.22	AMYRIS TO PARTICIPATE AT SEPTEMBER INVESTOR CONFERENCES (PR Newswire)
31.08.22	AMYRIS PUBLISHES SECOND ANNUAL ESG REPORT (PR Newswire)
09.08.22	AMYRIS, INC. REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS (PR Newswire)
03.08.22	AMYRIS TO PARTICIPATE AT THE UBS GENOMICS 2.0 AND MEDTECH INNOVATIONS SUMMIT (PR Newswire)
28.07.22	AMYRIS TO HOST SECOND QUARTER 2022 FINANCIAL RESULTS CONFERENCE CALL ON AUGUST 9 (PR Newswire)
23.06.22	AMYRIS BARRA BONITA FERMENTATION PLANT BEGINS INDUSTRIAL PRODUCTION (PR Newswire)
07.06.22	AMYRIS TO PARTICIPATE AT THE OPPENHEIMER 22nd ANNUAL CONSUMER CONFERENCE (PR Newswire)
23.05.22	AMYRIS PARTICIPATES IN INVESTOR CONFERENCES ON MAY 23, 24 AND 25, 2022 (PR Newswire)
23.05.22	AMYRIS TO PARTICIPATE AT MAY INVESTOR CONFERENCES (PR Newswire)
11.05.22	Pre-market Movers: U, ELBM, RCUS, EVEX, INO… (RTTNews)
10.05.22	AMYRIS, INC. REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS (PR Newswire)
03.05.22	AMYRIS TO HOST FIRST QUARTER 2022 FINANCIAL RESULTS CONFERENCE CALL ON MAY 10 (PR Newswire)
14.04.22	AMYRIS HOSTS SUCCESSFUL INVESTOR EVENT (PR Newswire)
11.04.22	AMYRIS STARTS COMMISSIONING OF INDUSTRY LEADING FERMENTATION PLANT (PR Newswire)
17.03.22	AMYRIS TO PARTICIPATE IN THE JEFFERIES VIRTUAL SYNTHETIC BIOLOGY WEEK (PR Newswire)
11.03.22	AMYRIS CLOSES ACQUISITION OF MENOLABS (PR Newswire)
01.03.22	AMYRIS, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS (PR Newswire)
28.02.22	AMYRIS TO PRESENT AT THE 42nd ANNUAL COWEN HEALTH CARE CONFERENCE (PR Newswire)
22.02.22	AMYRIS TO HOST FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS CONFERENCE CALL ON MARCH 1 (PR Newswire)
09.02.22	AMYRIS CLOSES ECOFABULOUS TRANSACTION, AND COMMENCES PRODUCTION OF CONSUMER PRODUCTS IN RENO, NEVADA PLANT (PR Newswire)
27.01.22	AMYRIS ANNOUNCES APPOINTMENT OF ANA DUTRA TO BOARD OF DIRECTORS (PR Newswire)
26.01.22	Pre-market Movers: GATO, XELA, NXPL, XCUR, MYNZ… (RTTNews)
24.01.22	AMYRIS TO ACQUIRE MENOLABS FOR MENOPAUSE WELLNESS ACCELERATING GROWTH OF CONSUMER BUSINESS (PR Newswire)
05.01.22	AMYRIS TO PRESENT AT THE 40th ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE (PR Newswire)
03.01.22	AMYRIS AND IMMUNITYBIO COMPLETE JOINT VENTURE FOR NEXT GENERATION COVID-19 RNA VACCINE (PR Newswire)
23.12.21	AMYRIS AND MINERVA FOODS COMPLETE JOINT VENTURE AND LICENSE AGREEMENTS TO SCALE LOW CARBON PROTEIN PRODUCTION PLATFORM (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Amyris Inc Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten